iEmoji Feeds @Ben Westphalen (BenWestphalen)

1.

BenWestphalen
Ben Westphalen @BenWestphalen
Buckle up…you are about to be impressed

Excited to see my friend, colleague (and mentee) @heinrich_kat present… twitter.com/i/web/status/1…
03 Mar 23 copy & paste +upvote -downvote Buckle up…you are about to be impressed ⭐️ Excited to see my friend, colleague (and mentee) @heinrich_kat present… https://t.co/083nFfiGvy

2.

BenWestphalen
Ben Westphalen @BenWestphalen
Funny disclaimer on my hotel bathtub
27 Jan 23 copy & paste +upvote -downvote Funny disclaimer on my hotel bathtub 🛀 https://t.co/UGiFNYJejJ
3.
BenWestphalen
Ben Westphalen @BenWestphalen
When you’re traveling in the present and stumble upon your past…this little guy (*1956 in ) brings back so many c… twitter.com/i/web/status/1…
28 Jan 23 copy & paste +upvote -downvote When you’re traveling in the present and stumble upon your past…this little guy (*1956 in 🇨🇿) brings back so many c… https://t.co/mv9eVbW2xK
4.
BenWestphalen
Ben Westphalen @BenWestphalen
Hot off the press Fresh for #weekendreading Pre-Proof versionRET aberrant cancers and RET inhibitor therapie… twitter.com/i/web/status/1…
Retweet of status by @VivekSubbiah
14 Jan 23 copy & paste +upvote -downvote ⚡️🚨 Hot off the press 👉 Fresh for #weekendreading Pre-Proof version👉RET aberrant cancers and RET inhibitor therapie… https://t.co/cWeQWx5xch
5.
BenWestphalen
Ben Westphalen @BenWestphalen
In 2017we reviewed all advanced sarcoma patients on Phase 1 #immunotherapy trials. We concluded that… twitter.com/i/web/status/1…
Retweet of status by @VivekSubbiah
18 Dec 22 copy & paste +upvote -downvote In 2017➡️we reviewed all advanced sarcoma patients on Phase 1 #immunotherapy trials. We concluded that… https://t.co/1c8bzFaTRs
6.
BenWestphalen
Ben Westphalen @BenWestphalen
A central question in metastatic #crcsm

Is recurrence free (RFS) correlated with overall survival (OS) after re… twitter.com/i/web/status/1…
04 Oct 22 copy & paste +upvote -downvote A central question in metastatic #crcsm 👇🏼 Is recurrence free (RFS) correlated with overall survival (OS) after re… https://t.co/9yV0io6mhv
7.
BenWestphalen
Ben Westphalen @BenWestphalen
The th @NEJM from #ASCO22
DESTINY Breast04
Trastuzumab Deruxtecan in Previously Treated HER2-Low Advanced… twitter.com/i/web/status/1…
Retweet of status by @weoncologists
06 Jun 22 copy & paste +upvote -downvote The 4⃣th @NEJM from #ASCO22 DESTINY Breast04 Trastuzumab Deruxtecan in Previously Treated HER2-Low Advanced… https://t.co/6gDW28Dpmu
8.
BenWestphalen
Ben Westphalen @BenWestphalen
Understanding the pathway

In @JCO_ASCO a detailed description on the effects of pathogenic germline variants in… twitter.com/i/web/status/1…
13 May 22 copy & paste +upvote -downvote 🤓Understanding the pathway🥳 In @JCO_ASCO a detailed description on the effects of pathogenic germline variants in… https://t.co/iT4DUD9aqm
9.
BenWestphalen
Ben Westphalen @BenWestphalen
Hot off the press in time for #BrainTumorAwarenessMonth Activity of Pemigatinib in Pilocytic Astrocytoma & FGF… twitter.com/i/web/status/1…
Retweet of status by @VivekSubbiah
05 May 22 copy & paste +upvote -downvote 🚨⭐️Hot off the press in time for #BrainTumorAwarenessMonth 👉🏼Activity of Pemigatinib in Pilocytic Astrocytoma & FGF… https://t.co/lPvJprargk

...but wait! There's more!

1.

fakhright
fakhright @fakhright
astaghfirullah peng.krim guaaaaaaaa..............a *salto sambil solat*
14 Jan 13 copy & paste +upvote -downvote astaghfirullah peng.krim guaaaaaaaa..............a *salto sambil solat* 🙈🙈🙊
https://www.iemoji.com/feed/BenWestphalen
Back to top